Logo image of CRBG

COREBRIDGE FINANCIAL INC (CRBG) Stock Fundamental Analysis

NYSE:CRBG - New York Stock Exchange, Inc. - US21871X1090 - Common Stock - Currency: USD

35.3  -0.2 (-0.56%)

After market: 35.3 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CRBG. CRBG was compared to 100 industry peers in the Financial Services industry. CRBG may be in some trouble as it scores bad on both profitability and health. CRBG scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRBG was profitable.
CRBG had a positive operating cash flow in the past year.
In the past 5 years CRBG has always been profitable.
CRBG had a positive operating cash flow in each of the past 5 years.
CRBG Yearly Net Income VS EBIT VS OCF VS FCFCRBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.18%, CRBG is doing worse than 71.00% of the companies in the same industry.
CRBG has a Return On Equity of 5.74%. This is in the lower half of the industry: CRBG underperforms 62.00% of its industry peers.
CRBG's Return On Invested Capital of 0.43% is on the low side compared to the rest of the industry. CRBG is outperformed by 69.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRBG is significantly below the industry average of 11.84%.
Industry RankSector Rank
ROA 0.18%
ROE 5.74%
ROIC 0.43%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBG Yearly ROA, ROE, ROICCRBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBG has a Profit Margin of 4.41%. This is in the lower half of the industry: CRBG underperforms 63.00% of its industry peers.
CRBG's Profit Margin has improved in the last couple of years.
CRBG has a Operating Margin (13.53%) which is comparable to the rest of the industry.
CRBG's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 4.41%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBG Yearly Profit, Operating, Gross MarginsCRBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRBG is destroying value.
CRBG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRBG has been reduced compared to 5 years ago.
CRBG has a worse debt/assets ratio than last year.
CRBG Yearly Shares OutstandingCRBG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBG Yearly Total Debt VS Total AssetsCRBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CRBG has a debt to FCF ratio of 6.39. This is a slightly negative value and a sign of low solvency as CRBG would need 6.39 years to pay back of all of its debts.
CRBG has a Debt to FCF ratio (6.39) which is in line with its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that CRBG has dependencies on debt financing.
CRBG has a Debt to Equity ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 6.39
Altman-Z N/A
ROIC/WACC0.06
WACC6.85%
CRBG Yearly LT Debt VS Equity VS FCFCRBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBG Yearly Current Assets VS Current LiabilitesCRBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.84% over the past year.
CRBG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 115.54% yearly.
The Revenue for CRBG has decreased by -20.43% in the past year. This is quite bad
CRBG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.01% yearly.
EPS 1Y (TTM)15.84%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%5.45%
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-19.08%

3.2 Future

Based on estimates for the next years, CRBG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.37% on average per year.
The Revenue is expected to grow by 2.76% on average over the next years.
EPS Next Y5.05%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
EPS Next 5Y11.37%
Revenue Next Year-1.65%
Revenue Next 2Y2.9%
Revenue Next 3Y2.66%
Revenue Next 5Y2.76%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBG Yearly Revenue VS EstimatesCRBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBG Yearly EPS VS EstimatesCRBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.20, the valuation of CRBG can be described as very cheap.
84.00% of the companies in the same industry are more expensive than CRBG, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.21, CRBG is valued rather cheaply.
CRBG is valuated cheaply with a Price/Forward Earnings ratio of 6.05.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBG indicates a rather cheap valuation: CRBG is cheaper than 83.00% of the companies listed in the same industry.
CRBG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.70.
Industry RankSector Rank
PE 7.2
Fwd PE 6.05
CRBG Price Earnings VS Forward Price EarningsCRBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRBG is valued a bit cheaper than 63.00% of the companies in the same industry.
CRBG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRBG is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.07
EV/EBITDA 13.02
CRBG Per share dataCRBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.43
PEG (5Y)0.06
EPS Next 2Y9.82%
EPS Next 3Y10.79%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.74%, CRBG has a reasonable but not impressive dividend return.
CRBG's Dividend Yield is a higher than the industry average which is at 4.97.
Compared to an average S&P500 Dividend Yield of 2.42, CRBG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

CRBG has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRBG Yearly Dividends per shareCRBG Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CRBG pays out 77.62% of its income as dividend. This is not a sustainable payout ratio.
DP77.62%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
CRBG Yearly Income VS Free CF VS DividendCRBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBG Dividend Payout.CRBG Dividend Payout, showing the Payout Ratio.CRBG Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC

NYSE:CRBG (7/1/2025, 8:12:57 PM)

After market: 35.3 0 (0%)

35.3

-0.2 (-0.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners90.71%
Inst Owner Change0.85%
Ins Owners0.34%
Ins Owner Change-5.51%
Market Cap19.42B
Analysts78.1
Price Target36.98 (4.76%)
Short Float %1.82%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP77.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-16 2025-06-16 (0.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.1%
Min EPS beat(2)-0.44%
Max EPS beat(2)0.65%
EPS beat(4)3
Avg EPS beat(4)4.33%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.1%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.39%
Min Revenue beat(2)-14.87%
Max Revenue beat(2)-11.92%
Revenue beat(4)0
Avg Revenue beat(4)-19.34%
Min Revenue beat(4)-28.97%
Max Revenue beat(4)-11.92%
Revenue beat(8)4
Avg Revenue beat(8)-2.25%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.33%
PT rev (3m)-7.05%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)-8.29%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-7.52%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-5.68%
Revenue NY rev (1m)-2.68%
Revenue NY rev (3m)-8.31%
Valuation
Industry RankSector Rank
PE 7.2
Fwd PE 6.05
P/S 1.24
P/FCF 10.07
P/OCF 10.07
P/B 1.62
P/tB 1.62
EV/EBITDA 13.02
EPS(TTM)4.9
EY13.88%
EPS(NY)5.84
Fwd EY16.54%
FCF(TTM)3.5
FCFY9.93%
OCF(TTM)3.5
OCFY9.93%
SpS28.38
BVpS21.77
TBVpS21.77
PEG (NY)1.43
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 5.74%
ROCE 0.54%
ROIC 0.43%
ROICexc 0.43%
ROICexgc 0.62%
OM 13.53%
PM (TTM) 4.41%
GM N/A
FCFM 12.35%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 6.39
Debt/EBITDA 5.28
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.59
Cash Conversion 82.71%
Profit Quality 280.23%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC6.85%
ROIC/WACC0.06
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)15.84%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%5.45%
EPS Next Y5.05%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
EPS Next 5Y11.37%
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-19.08%
Revenue Next Year-1.65%
Revenue Next 2Y2.9%
Revenue Next 3Y2.66%
Revenue Next 5Y2.76%
EBIT growth 1Y1.49%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.71%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-35.71%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%